2023. Cancer Stat Facts: Ovarian Cancer. In National Cancer Institut - Surveillance, Epidemiology, and End Result Program

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, Gaudet MM, Jemal A, Siegel RL (2018) Ovarian cancer statistics, 2018. CA Cancer J Clin 68:284–296

Article  PubMed  Google Scholar 

Cho KR, Shih IM (2009) Ovarian cancer. Annu Rev Pathol 4:287–313

Article  CAS  PubMed  Google Scholar 

Shih Ie M, Kurman RJ (2004) Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol 164:1511–1518

Article  PubMed  Google Scholar 

Singer G, Oldt R 3rd, Cohen Y, Wang BG, Sidransky D, Kurman RJ, Shih IM (2003) Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma. J Natl Cancer Inst 95:484–486

Article  CAS  PubMed  Google Scholar 

Ahrens TA, M. A., Ibrahim; Berger, Richard; Bielfeld, Alexandra; Boßung, Verena; Bräutigam, Karen; Brucker, Sara Yvonne; Doblinger, Jakob; Dürst, Matthias; Fehm, Tanja; Golic, Michaela; Grewe, Christoph; Griesinger, Georg; Günther, Veronika; Hadji, Peyman; Hagen, Kerstin; Hahnen, Eric; Hanker, Lars; Harbeck, Nadia; Henrich, Wolfgang; Hillemanns, Peter; Hoellen, Friederike; Jäger, Bernadette; Jahnke, Charlotte Marie; Juhasz-Böss, Ingolf; Kienast, Carolin Isabelle; Kiesel, Ludwig; Köhler, Günter; Köster, Frank; Kreis, Nina-Naomi; Krüssel, Jan-Steffen; Kyvernitakis, Ioannis; Liedtke, Cornelia; Louwen, Frank; Ludwig, Michael; Maass, Nicolai; Manz, Maike; Milde-Langosch, Karin; Neubauer, Hans; Oliveira-Ferrer, Leticia; Prieske, Katharina; Rall, Kristin Katharina; Rhiem, Kerstin; Ritter, Andreas; Rody, Achim; Römer, Thomas; Schleußner, Ekkehard; Schmalfeldt, Barbara; Schmutzler, Rita; Schultz, Silke; Solomayer, Erich-Franz; Stubert, Johannes; Stute, Petra; Verlohren, Stefan; Wölber, Linn; Yuan, Juping. 2016. Molekulare Gynäkologie und Geburtshilfe für die Praxis: Georg Thieme Verlag KG, Stuttgart

Lheureux S, Braunstein M, Oza AM (2019) Epithelial ovarian cancer: Evolution of management in the era of precision medicine. CA Cancer J Clin 69:280–304

Article  PubMed  Google Scholar 

Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G (2012) Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 124:192–198

Article  PubMed  Google Scholar 

Chardin L, Leary A (2021) Immunotherapy in Ovarian Cancer: Thinking Beyond PD-1/PD-L1. Front Oncol 11:795547

Article  CAS  PubMed  Google Scholar 

Riviere P, Goodman AM, Okamura R, Barkauskas DA, Whitchurch TJ, Lee S, Khalid N, Collier R, Mareboina M, Frampton GM, Fabrizio D, Sharabi AB, Kato S, Kurzrock R (2020) High Tumor Mutational Burden Correlates with Longer Survival in Immunotherapy-Naive Patients with Diverse Cancers. Mol Cancer Ther 19:2139–2145

Article  CAS  PubMed  PubMed Central  Google Scholar 

Strickler JH, Hanks BA, Khasraw M (2021) Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? Clin Cancer Res 27:1236–1241

Article  CAS  PubMed  Google Scholar 

Nardy AF, Freire-de-Lima L, Freire-de-Lima CG, Morrot A (2016) The Sweet Side of Immune Evasion: Role of Glycans in the Mechanisms of Cancer Progression. Front Oncol 6:54

Article  PubMed  PubMed Central  Google Scholar 

Sperandio M, Gleissner CA, Ley K (2009) Glycosylation in immune cell trafficking. Immunol Rev 230:97–113

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, Xu J, Li M, Zeng X, Wang J, Hu C (2020) Aberrant glycosylation in autoimmune disease. Clin Exp Rheumatol 38:767–775

PubMed  Google Scholar 

Lewis AL, Szymanski CM, Schnaar RL, Aebi M. 2022. Bacterial and Viral Infections. In Essentials of Glycobiology, ed. A Varki, RD Cummings, JD Esko, P Stanley, GW Hart, M Aebi, D Mohnen, T Kinoshita, NH Packer, JH Prestegard, RL Schnaar, PH Seeberger, pp. 555–68. Cold Spring Harbor (NY)

Cummings RD, Hokke CH, Haslam SM. 2022. Parasitic Infections. In Essentials of Glycobiology, ed. A Varki, RD Cummings, JD Esko, P Stanley, GW Hart, M Aebi, D Mohnen, T Kinoshita, NH Packer, JH Prestegard, RL Schnaar, PH Seeberger, pp. 569–82. Cold Spring Harbor (NY)

Stowell SR, Ju T, Cummings RD (2015) Protein glycosylation in cancer. Annu Rev Pathol 10:473–510

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thomas D, Rathinavel AK, Radhakrishnan P (2021) Altered glycosylation in cancer: A promising target for biomarkers and therapeutics. Biochim Biophys Acta Rev Cancer 1875:188464

Article  CAS  PubMed  Google Scholar 

RodrIguez E, Schetters STT, van Kooyk Y (2018) The tumour glyco-code as a novel immune checkpoint for immunotherapy. Nat Rev Immunol 18:204–211

Article  CAS  PubMed  Google Scholar 

Pinho SS, Reis CA (2015) Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer 15:540–555

Article  CAS  PubMed  Google Scholar 

Hirata T, Kizuka Y (2021) N-Glycosylation. Adv Exp Med Biol 1325:3–24

Article  CAS  PubMed  Google Scholar 

Reily C, Stewart TJ, Renfrow MB, Novak J (2019) Glycosylation in health and disease. Nat Rev Nephrol 15:346–366

Article  PubMed  PubMed Central  Google Scholar 

Briggs MT, Condina MR, Klingler-Hoffmann M, Arentz G, Everest-Dass AV, Kaur G, Oehler MK, Packer NH, Hoffmann P (2019) Translating N-Glycan Analytical Applications into Clinical Strategies for Ovarian Cancer. Proteomics Clin Appl 13:e1800099

Article  PubMed  Google Scholar 

Greville G, McCann A, Rudd PM, Saldova R (2016) Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer. Epigenetics 11:845–857

Article  PubMed  PubMed Central  Google Scholar 

Saldova R, Wormald MR, Dwek RA, Rudd PM (2008) Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers 25:219–232

Article  CAS  PubMed  Google Scholar 

Biskup K, Braicu EI, Sehouli J, Tauber R, Blanchard V (2014) The serum glycome to discriminate between early-stage epithelial ovarian cancer and benign ovarian diseases. Dis Markers 2014:238197

Article  PubMed  PubMed Central  Google Scholar 

Alley WR Jr, Vasseur JA, Goetz JA, Svoboda M, Mann BF, Matei DE, Menning N, Hussein A, Mechref Y, Novotny MV (2012) N-linked glycan structures and their expressions change in the blood sera of ovarian cancer patients. J Proteome Res 11:2282–2300

Article  CAS  PubMed  PubMed Central  Google Scholar 

Biskup K, Braicu EI, Sehouli J, Tauber R, Blanchard V (2017) The ascites N-glycome of epithelial ovarian cancer patients. J Proteomics 157:33–39

Article  CAS  PubMed  Google Scholar 

Grzeski M, Taube ET, Braicu EI, Sehouli J, Blanchard V, Klein O (2022) In Situ N-Glycosylation Signatures of Epithelial Ovarian Cancer Tissue as Defined by MALDI Mass Spectrometry Imaging. Cancers (Basel) 14:1021

Article  CAS  PubMed  Google Scholar 

Chen H, Deng Z, Huang C, Wu H, Zhao X, Li Y (2017) Mass spectrometric profiling reveals association of N-glycan patterns with epithelial ovarian cancer progression. Tumour Biol 39:1010428317716249

Article  PubMed  Google Scholar 

Briggs MT, Condina MR, Ho YY, Everest-Dass AV, Mittal P, Kaur G, Oehler MK, Packer NH, Hoffmann P (2019) MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans. Proteomics 19:e1800482

Article  PubMed  Google Scholar 

Pan J, Hu Y, Sun S, Chen L, Schnaubelt M, Clark D, Ao M, Zhang Z, Chan D, Qian J, Zhang H (2020) Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer. Nat Commun 11:6139

Article  CAS  PubMed  Google Scholar 

Raghavan S, Mehta P, Xie Y, Lei YL, Mehta G (2019) Ovarian cancer stem cells and macrophages reciprocally interact through the WNT pathway to promote pro-tumoral and malignant phenotypes in 3D engineered microenvironments. J Immunother Cancer 7:190

Article  PubMed  Google Scholar 

Hamester F, Legler K, Wichert B, Kelle N, Eylmann K, Rossberg M, Ding Y, Kurti S, Schmalfeldt B, Milde-Langosch K, Oliveira-Ferrer L (2019) Prognostic relevance of the Golgi mannosidase MAN1A1 in ovarian cancer: impact of N-glycosylation on tumour cell aggregation. Br J Cancer 121:944–953

Article  CAS  PubMed  Google Scholar 

Machado E, Kandzia S, Carilho R, Altevogt P, Conradt HS, Costa J (2011) N-Glycosylation of total cellular glycoproteins from the human ovarian carcinoma SKOV3 cell line and of recombinantly expressed human erythropoietin. Glycobiology 21:376–386